Photodynamic Therapy of Lung Cancer With Bronchial Artery Infusion of Photofrin | Zendy

Tetsuya Okunaka | Zendy; Harubumi Kato | Zendy; Chimori Konaka | Zendy; Kinya Furukawa | Zendy; Masahiko Harada | Zendy; Yutaka Yamamoto | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Photodynamic Therapy of Lung Cancer With Bronchial Artery Infusion of Photofrin

Author(s) -

Tetsuya Okunaka,

Harubumi Kato,

Chimori Konaka,

Kinya Furukawa,

Masahiko Harada,

Yutaka Yamamoto

Publication year - 1995

Publication title -

diagnostic and therapeutic endoscopy

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 0.158

H-Index - 24

eISSN - 1029-0516

pISSN - 1026-714X

DOI - 10.1155/dte.2.203

Subject(s) - medicine , photodynamic therapy , photosensitivity , lung cancer , photosensitizer , lung , carcinoma , cancer , bronchial artery , surgery , dermatology , chemistry , physics , organic chemistry , quantum mechanics

Photodynamic therapy (PDT) utilizing Photofrin is proving to be effective for the treatment of early stage lung cancer. However, wider clinical applications of Photofrin as a photosensitizer for various cancers are hampered by potentially serious and prolonged skin photosensitivity. To prevent these side effects and reduce the hospitalization period, we recently gave reduced doses of Photofrin by bronchial arterial infusion. Five patients with endoscopically evaluated minimally invasive carcinoma of the lung were given 0.7 mg/kg of Photofrin by bronchial arterial infusion 48 hr before PDT. Complete remission was obtained in all 5 cases and no case showed skin photosensitivity when exposed to sunlight under careful surveillance at one week after PDT.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research